Clinical Trial Update: Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy and safety of D-0120 in combination with allopurinol for gout. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Allopurinol (Allopurinol)
• D-0120

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Gout | Phase 2 | Status: ACTIVE_NOT_RECRUITING